Recruiting nowPhase 2
COMMETS- Combination MCI Metabolic Syndrome
Updated 2026-07-27 · NCT06072963See eligibility →
Sponsor
Clinical trials sponsored by Rutgers, The State University of New Jersey
Active studies whose public registry record names Rutgers, The State University of New Jersey as lead sponsor.
7active studies
4recruiting now
2countries represented
7largest site network
Current studies
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
Recruiting nowNot applicable
Metabolic Health, Bones and Nuts During Weight Loss in Adults
Updated 2026-05-13 · NCT06949280See eligibility →
Recruiting nowNot applicable
Extracellular Vesicles, Insulin Action, and Exercise
Updated 2026-01-23 · NCT06546085See eligibility →
Updated 2026-01-21 · NCT06518837See eligibility →
Opening soonPhase 2
Tirzepatide in the Treatment of Endometrial Cancer
Updated 2026-05-22 · NCT07605247See eligibility →
Opening soonNot applicable
Lactate and Glycerol Contribution to Gluconeogenesis
Updated 2025-12-02 · NCT06955130See eligibility →
Opening soonNot applicable
Implementation of a Peer Leader-facilitated Dyadic Intervention
Updated 2024-10-16 · NCT06643806See eligibility →
Related sponsors
Novo Nordisk A/S71Eli Lilly and Company67University of Colorado, Denver36Cairo University31Mayo Clinic29Norwegian University of Science and Technology25
How current is this page?
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
Does appearing here mean I qualify?
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.